| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |